Robots may sharpen needle accuracy for lung tumor ablation
NCT ID NCT07714629
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study compares two ways to guide a needle into lung nodules for heat-based destruction: robot-assisted CT-guided puncture versus the traditional manual method. Researchers will track how many CT scans and needle adjustments are needed, along with accuracy, success rates, and complications. The goal is to see if robotic guidance makes the procedure more efficient and safer for patients with peripheral lung nodules.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- robot-assisted CT-guided puncture
- What this could lead to
- If robot-assisted puncture proves more accurate and efficient, it could become the standard approach for lung nodule ablation, reducing procedure time and radiation exposure.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient selection. The robot may not improve outcomes for all nodule types or locations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
104 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jun 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients with peripheral pulmonary nodules who underwent CT-guided thermal ablation at the First Affiliated Hospital of Guangzhou Medical University. Participants received either robot-assisted or conventional manual puncture according to routine clinical practice.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years. * Patients with peripheral pulmonary nodules scheduled for CT-guided thermal ablation. * Eligible for either robot-assisted or conventional manual puncture according to routine clinical practice. * Written informed consent provided. Exclusion Criteria: * Pulmonary nodules unsuitable for percutaneous ablation because of proximity to major vessels, bronchi, or other critical structures. * Previous thoracic surgery or local treatment affecting puncture planning. * Severe cardiopulmonary dysfunction or other contraindications to CT-guided ablation. * Pregnancy. * Inability or unwillingness to provide informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pulmonary nodules are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI trained to tell dangerous lung nodules from harmless ones
- Can one needle biopsy and freeze lung nodules in a single visit?
- AI texts may nudge patients with High-Risk lung nodules toward timely care
- Which comes first? a trial tests the best sequence for lung nodule biopsies.
- Can a freezing needle outperform standard biopsy for lung nodules?
- Can a CT-Free navigation system pinpoint lung nodules with precision?